Article Details
Retrieved on: 2021-06-30 21:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Final trial results showed the coronavirus vaccine had an efficacy rate of just 48%, far lower than those developed by mRNA rivals BioNTech and ...
Article found on: www.batimes.com.ar
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here